[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337988-105":59,"doc-detail-337988-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","high-expression-of-yeats2-as-a-predictive-factor-of-poor-prognosis-in-patients-with-hepatocellular-carcinoma","High expression of YEATS2 as a predictive factor of poor prognosis in patients with hepatocellular carcinoma","","High expression of YEATS2 is investigated as a predictive factor of poor prognosis in hepatocellular carcinoma (HCC). Expression profiling and prognostic value of YEATS2 are analyzed using public databases including UALCAN, TIMER, OncoLnc, and survival and transcription analyses are performed via cBioPortal. Molecular functions and downstream signaling pathways are explored using STRING. YEATS2 is found elevated in HCC versus adjacent tissues, with distinct promoter methylation patterns linked to poorer survival and roles in morphogenesis and migration.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/high-expression-of-yeats2-as-a-predictive-factor-of-poor-prognosis-in-patients-with-hepatocellular-carcinoma/337988/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/high-expression-of-yeats2-as-a-predictive-factor-of-poor-prognosis-in-patients-with-hepatocellular-carcinoma/337988.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study investigating about YEATS2 in hepatocellular carcinoma?","Question",{"text":112,"@type":113},"The study evaluates whether YEATS2 expression correlates with prognosis in HCC and examines its relationship with expression patterns and clinical outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is YEATS2 expression assessed in this research?",{"text":117,"@type":113},"YEATS2 expression is analyzed using public databases (UALCAN, TIMER, OncoLnc, and cBioPortal) and experimentally validated in tissue samples using RT-qPCR and western blot.",{"name":119,"@type":110,"acceptedAnswer":120},"What major clinical finding is reported regarding YEATS2 levels?",{"text":121,"@type":113},"YEATS2 expression is significantly higher in HCC tissues than in adjacent non-malignant tissues, and high YEATS2 is associated with poorer survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337988,1791157089,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nHigh expression of YEATS2 as a predictive factor of poor prognosis in patients  \nwith hepatocellular carcinoma  \nNing Du1,3, Lili Yi2,3, Jiamu Wang1, Yongqiang Lei2, Xiaohui Bo1, Fangjie Guo2, Ruhao Wang2, Jian Chai2* & Guijie Liu1*  \nYEATS domain containing 2 (YEATS2), it may function as a proto-oncogene. This study aims to investigate if YEATS2 correlates with prognosis in hepatocellular carcinoma. The prognostic landscape of YEATS2 and its relationship with expression in hepatocellular carcinoma were deciphered  \nwith public databases, RT-qPCR and western-blot in tissue samples. The expression profiling and prognostic value of YEATS2 were explored using UALCAN, TIMER, OncoLnc database. Transcription and survival analyses of YEATS2 in hepatocellular carcinoma were investigated with cBioPortal database. The STRING database was explored to identify molecular functions and signaling pathways downstream of YEATS2. YEATS2 expression was significantly higher in hepatocellular carcinoma compared with adjacent non-malignant tissues. Promoter methylation of YEATS2 exhibited different patterns in hepatocellular carcinoma. High expression of YEATS2 was associated with poorer survival. Mechanistically, YEATS2 was involved in mediating multiple biological processes including morphogenesis and migration.  \nKeywords YEATS2, Expression, Survival, Hub genes, Function  \nHepatocellular carcinoma (HCC) is one of the most common malignancies and a leading cause of cancer-related mortality worldwide1. At present, the current situation is bleak for many patients with advanced HCC, as they often lack effective treatment options. The emergence of immune checkpoint inhibitors (ICIs) establishes immunotherapy as an effective treatment for hematological malignancies and solid tumors2. While generally safe, ICIscan cause immune-related adverse events (irAEs) that affect various organ systems3. Molecular classification based on oncogene mutation or abnormal expression provides new ideas for tumor research. This classification system has the potential to identify novel therapeutic targets, similar to the progress made in targeting EGFR or HER2 in lung and breast cancer4. Compared to traditional chemotherapy, it often leads to better survival ratesand reduced side effects5. Successful targeted therapy largely depends on specific biomarkers, but there is still a lack of specific targets for targeted therapy of HCC6.  \nThe human body harbors four major classes of YEATS domain-containing genes, namely YEATS4, MELL1, MELL3, and YEATS27,8. These genes encode proteins that are associated with complexes involved in chromosomal functions. For instance, they actively participate in the formation of histone acetyltransferase (HAT) complex and chromatin remodeling complex, thereby mediating epigenetic modification related signaling pathways9, 10. YEATS2 was first identified as a clone from a fetal brain cDNA library by NAGASE et al. who initially named it KIAA1197. YEATS2 gene encodes the scaffold subunit of Ada-two-A-containing (ATAC) complex, which is an important component of HATs complex and plays an important role in histone acetylation recognition7. However, YEATS2 is rarely reported in tumors, and it is only reported that it may function as a proto-oncogene in non-small cell lung cancer. In non-small cell lung cancer, YEATS2 is highly amplified, and YEATS2 knockdown can inhibit tumor cell growth, proliferation and metastasis11. However, the expression of YEATS2 in HCC and its biological function remain largely unknown. The aim of this study is to detect the expression of YEATS2 in HCC tissues and analyze its relationship with prognosis, in order to find a new target for the treatment of HCC.  \n1Department of Hepatobiliary Surgery, Liaocheng People’s Hospital, Liaocheng 252000, China. 2Joint Laboratory for Translational Medicine Research, Liaocheng People’s Hospital, Liaocheng 25200","cbCaibyEFye8bXEm","https://ap.wps.com/l/cbCaibyEFye8bXEm","pdf",2272139,13,"English","# Materials and methods\n## Tissue samples\n## Expression of YEATS2 in HCC by the database\n## Quantitative real-time polymerase chain reaction (RT-qPCR)","[{\"question\":\"What is the study investigating about YEATS2 in hepatocellular carcinoma?\",\"answer\":\"The study evaluates whether YEATS2 expression correlates with prognosis in HCC and examines its relationship with expression patterns and clinical outcomes.\"},{\"question\":\"How is YEATS2 expression assessed in this research?\",\"answer\":\"YEATS2 expression is analyzed using public databases (UALCAN, TIMER, OncoLnc, and cBioPortal) and experimentally validated in tissue samples using RT-qPCR and western blot.\"},{\"question\":\"What major clinical finding is reported regarding YEATS2 levels?\",\"answer\":\"YEATS2 expression is significantly higher in HCC tissues than in adjacent non-malignant tissues, and high YEATS2 is associated with poorer survival.\"}]","High expression of YEATS2 as a predictive factor of poor prognosis in patients with hepatocellular carcinoma | PDF",1790021441,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4af674249a216652749222d99768ba04.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16ffa9786b511ce81ee1542cc76c6fb0.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eea8909f2f132eb7164ddde21541b4b9.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a45a895fae658b626e0e4f179c32cabd.webp",980,1287]